MedPath

almotriptan

These highlights do not include all the information needed to use ALMOTRIPTAN TABLETS safely and effectively. See full prescribing information for ALMOTRIPTAN TABLETS.  ALMOTRIPTAN tablets, for oral use Initial U.S. Approval: 2001

Approved
Approval ID

6fa380c4-c885-4743-85bf-88819ae68645

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 24, 2023

Manufacturers
FDA

Ajanta Pharma USA Inc.

DUNS: 557554156

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

almotriptan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code27241-042
Application NumberANDA205523
Product Classification
M
Marketing Category
C73584
G
Generic Name
almotriptan
Product Specifications
Route of AdministrationORAL
Effective DateMarch 28, 2023
FDA Product Classification

INGREDIENTS (9)

microcrystalline celluloseInactive
Code: OP1R32D61U
Classification: IACT
almotriptan malateActive
Quantity: 12.5 mg in 1 1
Code: PJP312605E
Classification: ACTIM
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
povidone, unspecifiedInactive
Code: FZ989GH94E
Classification: IACT
sodium starch glycolate type A potatoInactive
Code: 5856J3G2A2
Classification: IACT
sodium stearyl fumarateInactive
Code: 7CV7WJK4UI
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
polyethylene glycol, unspecifiedInactive
Code: 3WJQ0SDW1A
Classification: IACT
hypromellose, unspecifiedInactive
Code: 3NXW29V3WO
Classification: IACT

almotriptan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code27241-041
Application NumberANDA205523
Product Classification
M
Marketing Category
C73584
G
Generic Name
almotriptan
Product Specifications
Route of AdministrationORAL
Effective DateMarch 28, 2023
FDA Product Classification

INGREDIENTS (9)

mannitolInactive
Code: 3OWL53L36A
Classification: IACT
almotriptan malateActive
Quantity: 6.25 mg in 1 1
Code: PJP312605E
Classification: ACTIM
polyethylene glycol, unspecifiedInactive
Code: 3WJQ0SDW1A
Classification: IACT
povidone, unspecifiedInactive
Code: FZ989GH94E
Classification: IACT
microcrystalline celluloseInactive
Code: OP1R32D61U
Classification: IACT
sodium starch glycolate type A potatoInactive
Code: 5856J3G2A2
Classification: IACT
sodium stearyl fumarateInactive
Code: 7CV7WJK4UI
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
hypromellose, unspecifiedInactive
Code: 3NXW29V3WO
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

almotriptan - FDA Drug Approval Details